Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Neuromuscular

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4 · 57.1%GRADE not reported 2 · 28.6%Very low 1 · 14.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Tripterygium polyglycoside vs corticosteroids

Improvement in disability grade after 4 weeks · patients with Guillain‐Barré syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tripterygium polyglycoside vs corticosteroids

Improvement in disability grade Defined as achievement of a specified degree of improvement · patients with Guillain‐Barré syndrome

It is very uncertain whether tripterygium polyglycoside changes improvement in disability grade Defined as achievement of a… compared with corticosteroids (very low certainty).

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
RR 1.47 [1.02, 2.11]
1 study · 43 participants
Very low

Tripterygium polyglycoside vs corticosteroids

Time from randomisation until recovery of unaided walking · patients with Guillain‐Barré syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tripterygium polyglycoside vs corticosteroids

Time from randomisation until discontinuation of ventilation (for those ventilated) · patients with Guillain‐Barré syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tripterygium polyglycoside vs corticosteroids

Death · patients with Guillain‐Barré syndrome

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
GRADE not reported

Tripterygium polyglycoside vs corticosteroids

Death or disability after 12 months · patients with Guillain‐Barré syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tripterygium polyglycoside vs corticosteroids

Participants with 1 or more serious adverse events · patients with Guillain‐Barré syndrome

1 finding from 1 review

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for… 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
GRADE not reported